Abnormal expression of CCL2 (MCP-1), an important monocyte/macrophage-mediated chemoattractant, has been documented in the lungs of patients with IPF and other ILDs [96]. This evidence concerns the gene CCL2 and idiopathic pulmonary fibrosis.